- Email: [email protected]
New technologies for toxicology—Meeting future challenges in drug safety
Available online at www.sciencedirect.com
Toxicology 246 (2008) 1
Editorial
New technologies for toxicology—Meeting future challenges in drug safety
The autumn meeting of the British Toxicology Society was held in Aberdeen, Scotland on the 10–11 September 2007 within the historic surroundings of Kings College in Old Aberdeen. The purpose-built Conference Centre provided state-of-the-art facilities for the 120 delegates. The excellence and range of speakers, both national and international, attracted a large international audience for an autumn meeting and provided the participants with an outstanding series of talks. The Continuing Education Programme explained some of the newer technologies used in toxicology including transgenic models and methods for in silico safety assessment. The full meeting started with presentations on some of the latest molecular and cell biology techniques being used to humanise experimental animals for toxicological research. Novel research fresh from the laboratory bench was then presented in six free communications—selected by the Scientific Sub-Committee of the British Toxicology Society. The final day began with a series of talks on cytokines and cytokine release syndrome—with particular emphasis on the recent TGN1412 phase I clinical trial (including a presentation from the Professor Sir Gordon Duff, who lead the enquiring into the safety of the trial). The final session covered the most
0300-483X/$ – see front matter © 2008 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.tox.2008.01.012
up-to-the-minute emerging technologies which are limited to a few groups in the world and are being used to examine toxicological problems. This special section provided overviews from eminent invited speakers. Overall, the meeting was a great success with high-quality science presented by a range of excellent speakers. Matthew C. Wright ∗,1 University of Newcastle upon Tyne, Medical School, Institute of Cellular Medicine (CALS), Level 2 William Leech Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK Heather M. Wallace 1 Aberdeen, UK ∗ Corresponding
author. Tel.: +44 191 222 7094; fax: +44 191 222 7179. E-mail address: [email protected] (M.C. Wright) 1 Both are co-organisers of the meeting. Available online 31 January 2008
Toxicology 246 (2008) 1
Editorial
New technologies for toxicology—Meeting future challenges in drug safety
The autumn meeting of the British Toxicology Society was held in Aberdeen, Scotland on the 10–11 September 2007 within the historic surroundings of Kings College in Old Aberdeen. The purpose-built Conference Centre provided state-of-the-art facilities for the 120 delegates. The excellence and range of speakers, both national and international, attracted a large international audience for an autumn meeting and provided the participants with an outstanding series of talks. The Continuing Education Programme explained some of the newer technologies used in toxicology including transgenic models and methods for in silico safety assessment. The full meeting started with presentations on some of the latest molecular and cell biology techniques being used to humanise experimental animals for toxicological research. Novel research fresh from the laboratory bench was then presented in six free communications—selected by the Scientific Sub-Committee of the British Toxicology Society. The final day began with a series of talks on cytokines and cytokine release syndrome—with particular emphasis on the recent TGN1412 phase I clinical trial (including a presentation from the Professor Sir Gordon Duff, who lead the enquiring into the safety of the trial). The final session covered the most
0300-483X/$ – see front matter © 2008 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.tox.2008.01.012
up-to-the-minute emerging technologies which are limited to a few groups in the world and are being used to examine toxicological problems. This special section provided overviews from eminent invited speakers. Overall, the meeting was a great success with high-quality science presented by a range of excellent speakers. Matthew C. Wright ∗,1 University of Newcastle upon Tyne, Medical School, Institute of Cellular Medicine (CALS), Level 2 William Leech Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK Heather M. Wallace 1 Aberdeen, UK ∗ Corresponding
author. Tel.: +44 191 222 7094; fax: +44 191 222 7179. E-mail address: [email protected] (M.C. Wright) 1 Both are co-organisers of the meeting. Available online 31 January 2008